Exercise for Breast Cancer

Overseen By Myriam Filion, PhD Student

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Alberta

Disqualifiers: Cardiac disease, Uncontrolled hypertension, Cancer recurrence, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 15

200 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will examine whether a mobile app increases exercise levels in breast cancer survivors after treatments, reduces fatigue, and improves physical functions. This experimental study has 200 participants placed into one of two groups. One group will be asked to use the cancer-specific exercise app over 12 weeks, and the other group will receive the cancer exercise guidelines. Exercise will be measured by self-report questionnaires before and after the intervention and three months later. Self-report questionnaires will measure fatigue and quality of life. This research will determine whether a simple mobile app helps increase exercise in breast cancer survivors. Mobile apps to increase exercise may be provided to all breast cancer survivors after treatments to help them recover and possibly improve survival.

Eligibility Criteria

This trial is for breast cancer survivors who have completed their treatments. It's designed to see if a mobile app can help them exercise more, feel less tired, and improve their physical functions.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants use the cancer-specific exercise app or receive exercise guidelines for 12 weeks

12 weeks

Baseline assessment, 12-week assessment

Follow-up

Participants are monitored for exercise levels, fatigue, and quality of life after the intervention

3 months

3-month follow-up assessment

Treatment Details

Interventions

• Exercise

Trial Overview The study is testing a mobile app that encourages exercise over 12 weeks against standard cancer exercise guidelines. Participants are split into two groups: one uses the app and the other follows guidelines. Their exercise levels and quality of life will be assessed through questionnaires.

Participant Groups

Group I: Cancer-specific exercise app Experimental Treatment 1 Intervention

Participants randomized in this group will be asked to use the app for 12 weeks. Participants will be ask to preferably spread each exercise session over different days of the week. While exercise equipment is not required, the app includes options for using elastic resistance bands or dumbbells. Following baseline assessment and randomization, participants in the intervention group will receive a brief instructional video on how to download and use the app, along with access to a website offering support materials, guidelines, and additional instructional videos. All participants will complete questionnaires at baseline, 12 weeks (post-intervention), and 3 months follow-up.

Group II: Usual care Active Control 1 Intervention

This group will received the ACSM exercise guidelines.

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials

957

Recruited

437,000+